Skip to main content

Advertisement

Log in

Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review

  • Review
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

The European Working Group on Sarcopenia in Older People (EWGSOP) recently updated the definition and diagnostic criteria to assess sarcopenia, which can result in important changes in sarcopenia prevalence in older adults.

Aim

To compare the prevalence of sarcopenia through the diagnostic criteria and definition proposed by the first (EWGSOP1) and recent (EWGSOP2) European consensus in older adults. We also aimed to evaluate which sarcopenia consensus is better associated with unfavorable health outcomes.

Methods

The review followed PRISMA guidelines. Embase, Medline (PubMed), Scopus and Web of Science were searched from 2018 to February 2021. The systematic review protocol was registered at PROSPERO (CRD42020213303). The search, selection, and evaluation processes were done in a duplicate and independent manner.

Results

Of the 298 potentially eligible articles, 9 were included in this review. The prevalence of sarcopenia was 17.7% by EWGSOP1 and 11% by EWGSOP2. Evaluating all the studies, the sarcopenia prevalence ranged from 6.2 to 35.3% for the EWGSOP1, and from 3.2 to 26.3% for the EWGSOP2. Five studies have evaluated the association between the prevalence of sarcopenia (EWGSOP1 versus EWGSOP2) and unfavorable health outcomes, in which three studies showed that EWGSOP1 was better associated with increased risk of hospitalization and/or mortality.

Conclusion

In comparison with EWGSOP1, the prevalence of sarcopenia in older adults decreased when diagnosed according to EWGSOP2. Based on limited evidence, EWGSOP2 seems to be worse for predicting unfavorable outcomes compared with EWGSOP1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rosenberg IH (1997) Symposium: sarcopenia: diagnosis and mechanisms sarcopenia: origins and clinical relevance 1. J Nutr 127:990–991

    Article  Google Scholar 

  2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cruz-Jentoft AJ, Bahat GG, Bauer JJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169

    Article  PubMed  Google Scholar 

  4. Kim H, Hirano H, Edahiro A et al (2016) Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16:110–122. https://doi.org/10.1111/ggi.12723

    Article  PubMed  Google Scholar 

  5. Pagotto V, Silveira EA (2014) Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr 59:288–294. https://doi.org/10.1016/j.archger.2014.05.009

    Article  PubMed  Google Scholar 

  6. Bachettini NP, Bielemann RM, Barbosa-Silva TG et al (2020) Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People. Eur J Clin Nutr 74:573–580. https://doi.org/10.1038/s41430-019-0508-8

    Article  CAS  PubMed  Google Scholar 

  7. Costanzo L, De Vincentis A, Di Iorio A et al (2020) Impact of low muscle mass and low muscle strength according to EWGSOP2 and EWGSOP1 in community-dwelling older people. J Gerontol Ser A 75:1324–1330. https://doi.org/10.1093/gerona/glaa063

    Article  Google Scholar 

  8. Jang I-Y, Lee E, Lee H et al (2020) Characteristics of sarcopenia by European consensuses and a phenotype score. J Cachexia Sarcopenia Muscle 11:497–504. https://doi.org/10.1002/jcsm.12507

    Article  PubMed  Google Scholar 

  9. Downes MJ, Brennan ML, Williams HC, Dean RS (2016) Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open 6:1–7. https://doi.org/10.1136/bmjopen-2016-011458

    Article  Google Scholar 

  10. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: Ottawa Hosp. Res. Inst. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

  11. Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE 12:1–16. https://doi.org/10.1371/journal.pone.0169548

    Article  CAS  Google Scholar 

  12. Krzymińska-Siemaszko R, Deskur-Śmielecka E, Kaluźniak-Szymanowska A et al (2020) Comparison of diagnostic performance of SARC-F and its two modified versions (SARC-CalF and SARC-F+EBM) in community-dwelling older adults from Poland. Clin Interv Aging 15:583–594. https://doi.org/10.2147/CIA.S250508

    Article  PubMed  PubMed Central  Google Scholar 

  13. Shafiee G, Heshmat R, Ostovar A et al (2020) Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program. J Diabetes Metab Disord. https://doi.org/10.1007/s40200-020-00553-w

    Article  PubMed  PubMed Central  Google Scholar 

  14. Yang L, Yao X, Shen J et al (2019) Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol 130:110798. https://doi.org/10.1016/j.exger.2019.110798

    Article  CAS  PubMed  Google Scholar 

  15. Tang T, Xie L, Tan L et al (2020) Inflammatory indexes are not associated with sarcopenia in Chinese community-dwelling older people: a cross-sectional study. BMC Geriatr 20:457. https://doi.org/10.1186/s12877-020-01857-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Locquet M, Beaudart C, Petermans J et al (2019) EWGSOP2 versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc 20:384–385. https://doi.org/10.1016/j.jamda.2018.11.027

    Article  PubMed  Google Scholar 

  17. Sobestiansky S, Michaelsson K, Cederholm T (2019) Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr. https://doi.org/10.1186/s12877-019-1338-1

    Article  PubMed  PubMed Central  Google Scholar 

  18. Krzyminska-Siemaszko R, Deskur-Smielecka E, Kaluzniak-Szymanowska A et al (2020) Comparison of diagnostic performance of sarc-f and its two modified versions (SARC-CaIF and SARC-F plus EBM) in community-dwelling older adults from Poland. Clin Interv Aging 15:583–594. https://doi.org/10.2147/CIA.S250508

    Article  PubMed  PubMed Central  Google Scholar 

  19. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520

    Article  CAS  PubMed  Google Scholar 

  20. Janssen I, Heymsfield SB, Ross R (2002) Low Relative skeletal muscle mass (Sarcopenia) in older persons is associated with functional impairment and physical disability. Am Geriatr Soc 50:889–896. https://doi.org/10.1046/j.1532-5415.2002.50216.x

    Article  Google Scholar 

  21. Sergi G, De Rui M, Veronese N et al (2015) Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr 34:667–673. https://doi.org/10.1016/j.clnu.2014.07.010

    Article  PubMed  Google Scholar 

  22. Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393:2636–2646. https://doi.org/10.1016/S0140-6736(19)31138-9

    Article  PubMed  Google Scholar 

  23. Martone AM, Marzetti E, Salini S et al (2020) Sarcopenia identified according to the EWGSOP2 definition in community-living people: prevalence and clinical features. J Am Med Dir Assoc 21:1470–1474. https://doi.org/10.1016/j.jamda.2020.03.007

    Article  PubMed  Google Scholar 

  24. Cruz RPF, Barreiro SM, Mendonça AM et al (2020) Calf circumference is similarly associated with fat mass and lean mass in postmenopausal women with high body fat percentage. Nutrire 45:6. https://doi.org/10.1186/s41110-019-0109-2

    Article  Google Scholar 

  25. Phu S, Vogrin S, Zanker J et al (2019) Agreement between initial and revised european working group on sarcopenia in older people definitions. J Am Med Dir Assoc 20:382-383.e1. https://doi.org/10.1016/j.jamda.2018.11.026

    Article  PubMed  Google Scholar 

  26. Yee XS, Ng YS, Allen JC et al (2021) Performance on sit-to-stand tests in relation to measures of functional fitness and sarcopenia diagnosis in community-dwelling older adults. Eur Rev Aging Phys Act 18:1–11. https://doi.org/10.1186/s11556-020-00255-5

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001, National Council for Scientific and Technological Development (CNPq) and Federal University of Lavras (UFLA). EPO would like to thank “Conselho Nacional de Desenvolvimento Científico e Tecnológico” (CNPq, Brazil, 304205/2019-2).

Author information

Authors and Affiliations

Authors

Contributions

LVF, AEGP, and ACBS designed the study, developed the study protocol, and performed all analyses, and oversaw the management of all aspects of the study. LVF and AEGP conducted the literature search and participated in screening, full-text review, and data extraction. ICC, AFS, EPO, and LCJP participated full-text review and advised on analysis and contributed to the interpretation of findings. EPO and LCJP contributed equally to this work. All authors contributed to the writing of the final manuscript and approved the final version for submission.

Corresponding author

Correspondence to Laura Cristina Jardim Porto.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernandes, L.V., Paiva, A.E.G., Silva, A.C.B. et al. Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review. Aging Clin Exp Res 34, 505–514 (2022). https://doi.org/10.1007/s40520-021-01951-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-021-01951-7

Keywords

Navigation